Our mission is to become the world leader in the development of targeted therapies for #MASH and viral diseases to address important unmet medical needs. Learn more here: https://bit.ly/45jYor3
Aligos Therapeutics’ Post
More Relevant Posts
-
On this rare Feb. 29th, let’s support & bring awareness to rare diseases. While each rare disease affects only a small percentage of the population, >7000 rare diseases have been identified and affect >300M people globally. Many rare conditions are life-threatening and most do not have treatments. Development of treatments is challenging due to the complex biology, lack of understanding, and the difficulty of conducting clinical trials within the inherently small population of patients. Click here to watch a video to learn more: https://lnkd.in/dXijzgdd @rarediseaseday #RareDiseaseDay
To view or add a comment, sign in
-
-
On this rare Feb. 29th, let’s support & bring awareness to rare diseases. While each rare disease affects only a small percentage of the population, >7000 rare diseases have been identified and affect >300M people globally. Many rare conditions are life-threatening and most do not have treatments. Development of treatments is challenging due to the complex biology, lack of understanding, and the difficulty of conducting clinical trials within the inherently small population of patients. Click here to watch a video to learn more: https://lnkd.in/dXijzgdd @rarediseaseday #RareDiseaseDay
To view or add a comment, sign in
-
-
This week I plan to make the first Webinar presentation on my clinical research hypothesis of Spike Triggered AutOimmune Response Mechanism (STORM). Our original research premise was that severe COVID-19 is a viral mediated autoimmune response to SARS-COV2 primarily in people with elevated levels of serum ACE2. There are other proteins that bind to the spike, so how will that change disease manifestation? While the Covid virus continues to circulate widely, what could be some of the medium and long term implications of recurrent infections? Many people think this is over, and I also have that hope, but based on what I am seeing, we are in the middle of another wave. Severe COVID-19 will no longer present as lung disease (still the case in some patients) but a wide range of disconnected organ involvement. How can the medical community recognise the patterns and intervene when appropriate? Happy to see further ideas to expand this concept. #covid #medicine #research
To view or add a comment, sign in
-
-
New research in The FASEB Journal studied the roles of CCR6 and CCL20 molecules in acute kidney disease. Findings propose that targeting this pathway could be a possible strategy for treating and managing kidney diseases. Read the article ➡️https://hubs.ly/Q02hFnqm0
To view or add a comment, sign in
-
-
Today is Rare Disease Day, a day to raise awareness about rare diseases and their impact on individuals and their families worldwide. 🧬💡 Our latest blog article puts rare disease in the spotlight. It is full of information, including how many rare diseases there are, what causes them, how they are diagnosed and treated, and examples of rare diseases. By sharing information and resources, Medicover Genetics can help to promote understanding, advocacy and solidarity for those living with rare diseases. Click here to read the full article: https://lnkd.in/dgDTinqm Follow us for more interesting articles about rare disease. #RareDiseaseDay #genetictesting #MedicoverGenetics
To view or add a comment, sign in
-
-
Call for #abstracts! Do you have research on viral hepatitis and liver disease? Showcase your work by submitting an abstract and join us at the Conference on Liver Disease in Africa 2024. Explore the list of topics and submit today > amededu.co/4aFkK7M #COLDA #COLDA2024 #Hepatology
The abstract portal for #COLDA2024 is open! Present your latest research at the Conference on Liver Disease in Africa 2024. In its 7th edition, the conference offers 11 different abstract categories, welcoming abstracts across prevention, diagnosis, and treatment of liver disease. Submissions are welcome in both English and French languages. View the categories and submit here 👉 amededu.co/4aFkK7M #COLDA #SOLDA #LiverDisease #Hepatitis
To view or add a comment, sign in
-
-
🗓 Did you know February is Rare Liver Diseases Awareness Month? While the #liver plays a vital role in our health, many rare liver diseases remain under the radar. Here's why we need to talk about it: 👉 There are over 100 rare liver diseases, affecting millions globally. 👉 Many remain undiagnosed or misdiagnosed due to their rarity and complex symptoms. 👉 #Patients often face long diagnostic journeys and limited #treatment options. 💫 At BlueDil International, we stand proudly in support of this crucial #awareness campaign. Many of our partners have dedicated years of their work to some rare liver conditions, including primary bile acid synthesis disorders and urea cycle disorders. 🙌 This month, let's spread awareness - share this post and use #RareAware #rarediseases #orphandrugs
To view or add a comment, sign in
-
-
"Relapsing polychondritis, even among autoimmune diseases, is one of the more challenging diagnoses to make." - Rennie Rhee, MD, MS of the Penn Relapsing Polychondritis Center That's why we invest so heavily in research. Learn more about how we're fueling the next wave of RP and related autoimmune disease research: https://lnkd.in/eAVdwukE #autoimmunediseases #research
To view or add a comment, sign in
-
Autoimmune diseases are a significant and growing concern in modern medicine. Why not read the blog to learn about upcoming developments in the field of autoimmune diseases? https://loom.ly/YYGIreA #autoimmunedisease #autoimmunity #immunesystem
To view or add a comment, sign in
-